LivaNova Plc
(NASDAQ : LIVN)

( )
LIVN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
-0.03%151.300.7%$2362.98m
MDTMedtronic Plc
0.58%112.370.6%$509.04m
TMOThermo Fisher Scientific, Inc.
0.50%321.001.0%$376.65m
ABTAbbott Laboratories
1.26%85.980.8%$368.11m
ISRGIntuitive Surgical, Inc.
0.52%584.002.4%$322.38m
BDXBecton, Dickinson & Co.
1.72%265.561.1%$308.84m
EWEdwards Lifesciences Corp.
0.68%232.181.2%$294.37m
SYKStryker Corp.
0.02%199.791.3%$265.85m
BSXBoston Scientific Corp.
1.96%44.681.1%$255.26m
DXCMDexCom, Inc.
-4.88%202.008.3%$199.05m
BAXBaxter International, Inc.
0.60%83.511.8%$198.07m
MTDMettler-Toledo International, Inc.
1.76%775.765.4%$163.59m
PODDInsulet Corp.
-3.84%173.286.7%$149.24m
ALGNAlign Technology, Inc.
-2.49%268.396.4%$147.19m
ABMDABIOMED, Inc.
0.48%180.013.3%$146.71m

Company Profile

LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular, Neuromodulation, and Others. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The Other segment consists of company's shared service expenses for finance, legal, human resources, information technology, and new ventures. Its products include VNS therapy system. oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, and cannulae. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.